Literature DB >> 26584067

Engaging Patients Across the Spectrum of Medical Product Development: View From the US Food and Drug Administration.

Nina L Hunter1, Kathryn M O'Callaghan1, Robert M Califf2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26584067     DOI： 10.1001/jama.2015.15818

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  18 in total

1.  Health policy: Addressing conflicts of interest of public speakers at advisory committee meetings.

Authors:  Matthew S McCoy; Ezekiel J Emanuel
Journal:  Nat Rev Clin Oncol       Date:  2016-04-13       Impact factor: 66.675

2.  Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop.

Authors:  Heather L Benz; Ting-Hsuan Joyce Lee; Jui-Hua Tsai; John F P Bridges; Sara Eggers; Megan Moncur; Fadia T Shaya; Ira Shoulson; Erica S Spatz; Leslie Wilson; Anindita Saha
Journal:  Patient       Date:  2019-12       Impact factor: 3.883

3.  Engaging patients and caregivers in prioritizing symptoms impacting quality of life for Duchenne and Becker muscular dystrophy.

Authors:  Ilene L Hollin; Holly Peay; Ryan Fischer; Ellen M Janssen; John F P Bridges
Journal:  Qual Life Res       Date:  2018-05-26       Impact factor: 4.147

4.  Stimulating Patient Engagement in Medical Device Development in Kidney Disease: A Report of a Kidney Health Initiative Workshop.

Authors:  Frank P Hurst; Dolph Chianchiano; Linda Upchurch; Benjamin R Fisher; Jennifer E Flythe; Celeste Castillo Lee; Terri Hill; Carolyn Y Neuland
Journal:  Am J Kidney Dis       Date:  2017-04-27       Impact factor: 8.860

5.  The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer.

Authors:  Andrea Bever; Jackie Manthorne; Tissa Rahim; Layla Moumin; Shelagh M Szabo
Journal:  Patient       Date:  2021-10-13       Impact factor: 3.883

Review 6.  Conceptualization of utility in translational clinical genomics research.

Authors:  Hadley Stevens Smith; Kyle B Brothers; Sara J Knight; Sara L Ackerman; Christine Rini; David L Veenstra; Amy L McGuire; Benjamin S Wilfond; Janet Malek
Journal:  Am J Hum Genet       Date:  2021-10-22       Impact factor: 11.025

Review 7.  Stem cell therapy for heart failure: Ensuring regenerative proficiency.

Authors:  Andre Terzic; Atta Behfar
Journal:  Trends Cardiovasc Med       Date:  2016-01-28       Impact factor: 6.677

8.  Role of Patients and Parents in Pediatric Drug Development.

Authors:  Vivian W L Tsang; Leanne West; Christine Woods; Chester J Koh; Susan McCune; Theresa Mullin; Sharon R Smith; Segolene Gaillard; Joana Claverol; Begonya Nafria; Jennifer Preston; Pamela Dicks; Charles Thompson
Journal:  Ther Innov Regul Sci       Date:  2019-01-20       Impact factor: 1.778

9.  Integrating Patient Perspectives into Medical Device Regulatory Decision Making to Advance Innovation in Kidney Disease.

Authors:  Michelle E Tarver; Carolyn Neuland
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-03       Impact factor: 8.237

Review 10.  Patients, Families, and Communities COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.

Authors:  Frederick Isasi; Mary D Naylor; David Skorton; David C Grabowski; Sandra Hernández; Valerie Montgomery Rice
Journal:  NAM Perspect       Date:  2021-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.